News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
BIO Applauds Incoming Administration's Decision…
President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…
Trump Administration Move to Issue RFS Waivers …
Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year. “This…
BIO Releases Statement Concerning Future…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions:   "As of today BIO will be pausing our political giving so we can…
Letters, Testimony, & Comments
BIO Comments on FDA’s Public Workshop on…
On Wednesday, December 23rd, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s October 2020 public workshop titled, “New Drugs Regulatory Program Modernization: Implementation of the Integrated Assessment of Marketing…
BIO Submits Comments on Final EPA PIP rule
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on proposed revisions to regulations related to the oversight of certain plant…
BIO Submits Testimony to Senate Hearing on Ag…
Innovative breakthroughs can secure our nation’s food supply by reducing greenhouse gas emissions throughout agricultural supply chains; strengthening producers’ resiliency to climate change while increasing production; and tackling hunger and…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
The hunger pandemic biotechnology
January 13, 2021
Science experts have been sounding the alarm since March when lockdowns started, that this pandemic is a drill for the impending climate change pandemic.  “Many organizations have warned that COVID-19 is only a…
Placeholder Image
January 12, 2021
In the wake of the violent riot at the U.S. Capitol last week, Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Heath condemned the attack and announced that all political donations by…
WuXi Global Forum
January 12, 2021
If there’s a silver lining to the past year, it’s that we’ve learned a lot about how to accelerate innovation and get breakthroughs to patients, even in the most trying times. On January 11, 2021, BIO President and CEO…